Jake Emmerson

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Locally Advanced

Cardiac Surgery

Top Venues

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Bianca Grosser, Jake Emmerson, Nic Gabriel Reitsam, David Cunningham, Matthew Nankivell, Ruth E Langley, William H Allum, Martin Trepel, Bruno Märkl, Heike I Grabsch
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British journal of cancer (2023)
Bianca Grosser, Jake Emmerson, Nic Gabriel Reitsam, David Cunningham, Matthew Nankivell, Ruth E Langley, William H Allum, Martin Trepel, Bruno Märkl, Heike I Grabsch
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British journal of cancer 130 (3) (2023)
Bianca Grosser, Jake Emmerson, Nic Gabriel Reitsam, David Cunningham, Matthew Nankivell, Ruth E Langley, William H Allum, Martin Trepel, Bruno Märkl, Heike I Grabsch
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British journal of cancer 130 (3) (2023)
Bianca Grosser, Jake Emmerson, Nic Gabriel Reitsam, David Cunningham, Matthew Nankivell, Ruth E Langley, William H Allum, Martin Trepel, Bruno Märkl, Heike I Grabsch
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British journal of cancer 130 (3) (2023)
Bianca Grosser, Jake Emmerson, Nic Gabriel Reitsam, David Cunningham, Matthew Nankivell, Ruth E Langley, William H Allum, Martin Trepel, Bruno Märkl, Heike I Grabsch
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British journal of cancer 130 (3) (2023)
Bianca Grosser, Jake Emmerson, Nic Gabriel Reitsam, David Cunningham, Matthew Nankivell, Ruth E Langley, William H Allum, Martin Trepel, Bruno Märkl, Heike I Grabsch
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British journal of cancer 130 (3) (2023)
Bianca Grosser, Jake Emmerson, Nic Gabriel Reitsam, David Cunningham, Matthew Nankivell, Ruth E Langley, William H Allum, Martin Trepel, Bruno Märkl, Heike I Grabsch
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British journal of cancer 130 (3) (2023)
Jake Emmerson, Susan Todd, Julia M Brown
Recommendations for designing and analysing multi-arm non-inferiority trials: a review of methodology and current practice. Trials 22 (1) (2021)